Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2013; 19(36): 6055-6061
Published online Sep 28, 2013. doi: 10.3748/wjg.v19.i36.6055
Figure 1
Figure 1 Survival curves between α-fetoprotein-producing gastric cancer and α-fetoprotein-non producing gastric cancer. The postoperative cause-specific 5-year survival rate of patients with α-fetoprotein (AFP)-producing gastric cancer (GC) was significantly poorer than that of patients without AFP-producing GC (5-year survival rate: 50.3% and 76.5%, P = 0.002).